HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dep's debt restructuring would pay creditors in full plus interest, company asserts in filing.

This article was originally published in The Rose Sheet

Executive Summary

DEP DEBT REORGANIZATION WOULD ALLOW CREDITOR PAYMENT IN FULL, COMPANY ASSERTS in a Chapter 11 bankruptcy petition filed with the federal Bankruptcy Court in Wilmington, Del. on April 1. The plan would provide full payment plus interest to the company's secured lenders and unsecured creditors, according to the firm. Dep reported total liabilities of $77.3 mil., comprising $62.2 mil in secured debt and $15.1 mil. in unsecured debt. All unpaid principal and accrued interest must be paid by Sept. 30, 2005, a nine-year extension of the original maturity date of Dec. 31, 1996, the Chapter 11 filing states. Dep's assets total $84 mil.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel